Annual Retained Earnings
-$116.66 M
-$36.01 M-44.65%
December 31, 2023
Summary
- As of February 8, 2025, MLTX annual retained earnings is -$116.66 million, with the most recent change of -$36.01 million (-44.65%) on December 31, 2023.
- During the last 3 years, MLTX annual retained earnings has fallen by -$63.01 million (-117.47%).
- MLTX annual retained earnings is now -117.47% below its all-time high of -$53.64 million, reached on December 31, 2021.
Performance
MLTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$189.99 M
-$35.39 M-22.89%
September 30, 2024
Summary
- As of February 8, 2025, MLTX quarterly retained earnings is -$189.99 million, with the most recent change of -$35.39 million (-22.89%) on September 30, 2024.
- Over the past year, MLTX quarterly retained earnings has dropped by -$35.39 million (-22.89%).
- MLTX quarterly retained earnings is now -254.17% below its all-time high of -$53.64 million, reached on December 31, 2021.
Performance
MLTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
MLTX Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.6% | -22.9% |
| 3 y3 years | -117.5% | -254.2% |
| 5 y5 years | -117.5% | -254.2% |
MLTX Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -117.5% | at low | -254.2% | at low |
| 5 y | 5-year | -117.5% | at low | -254.2% | at low |
| alltime | all time | -117.5% | at low | -254.2% | at low |
MoonLake Immunotherapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$189.99 M(+22.9%) |
| Jun 2024 | - | -$154.60 M(+18.6%) |
| Mar 2024 | - | -$130.33 M(+11.7%) |
| Dec 2023 | -$116.66 M | -$116.66 M(+6.8%) |
| Sep 2023 | - | -$109.22 M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$99.79 M(+11.3%) |
| Mar 2023 | - | -$89.66 M(+11.2%) |
| Dec 2022 | -$80.65 M(+50.3%) | -$80.65 M(+17.2%) |
| Sep 2022 | - | -$68.79 M(+17.2%) |
| Jun 2022 | - | -$58.68 M(+9.4%) |
| Dec 2021 | -$53.64 M | -$53.64 M |
FAQ
- What is MoonLake Immunotherapeutics annual retained earnings?
- What is the all time high annual retained earnings for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual retained earnings year-on-year change?
- What is MoonLake Immunotherapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly retained earnings year-on-year change?
What is MoonLake Immunotherapeutics annual retained earnings?
The current annual retained earnings of MLTX is -$116.66 M
What is the all time high annual retained earnings for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual retained earnings is -$53.64 M
What is MoonLake Immunotherapeutics annual retained earnings year-on-year change?
Over the past year, MLTX annual retained earnings has changed by -$36.01 M (-44.65%)
What is MoonLake Immunotherapeutics quarterly retained earnings?
The current quarterly retained earnings of MLTX is -$189.99 M
What is the all time high quarterly retained earnings for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly retained earnings is -$53.64 M
What is MoonLake Immunotherapeutics quarterly retained earnings year-on-year change?
Over the past year, MLTX quarterly retained earnings has changed by -$35.39 M (-22.89%)